Table 3.
Salmonella serotype distribution and number and percent of intermediate and resistant isolates to antimicrobial agents
| Serotype | Number | No. of intermediately resistant and resistant isolates | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amp | Amc | Cf | Cip | Gm | K | Tmp | Te | Su | S | Nitro | Na | N | |||||||||||||||
| I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | ||
| Aberdeen | 1 | – | – | – | – | – | – | 1 | – | – | – | 1 | – | – | – | 1 | – | 1 | – | 1 | – | – | 1 | 1 | – | 1 | – |
| Dublin | 3 | – | – | – | 2 | – | – | – | – | – | – | – | – | – | – | – | 1 | – | 3 | – | – | – | – | – | – | – | |
| I:6,7,14:–:I,w | 1 | – | 1 | – | 1 | – | 1 | 1 | – | – | – | – | – | – | – | 1 | – | – | – | 1 | – | – | 1 | 1 | – | – | – |
| Kentucky | 5 | – | 5 | 2 | 3 | – | 5 | – | 5 | – | 5 | 4 | – | – | 1 | – | 5 | – | 5 | – | 5 | 4 | 1 | – | 5 | – | 2 |
| LivingstoneVar.14+ | 1 | – | – | – | – | – | – | 1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1 | – | – |
| Mikawasima | 1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1 | – | – | 1 | – | – | – | – | – | |
| Saintpaul | 6 | 1 | – | – | – | 1 | – | – | – | – | – | 4 | – | – | – | 4 | – | 3 | 2 | 5 | 1 | 2 | 3 | – | – | 3 | – |
| Typhimurium | 7 | – | – | – | 2 | – | – | – | – | – | 3 | – | – | – | 4 | – | 3 | – | 7 | – | 1 | 1 | 1 | – | 1 | – | |
| Virchow | 5 | – | 3 | 3 | – | – | 3 | 1 | – | 1 | 1 | 1 | – | – | – | – | 1 | 1 | 1 | 1 | 2 | 1 | 3 | – | 2 | – | – |
| Total | 30 | 1 | 9 | 5 | 4 | 5 | 9 | 4 | 5 | 1 | 6 | 13 | – | – | – | 10 | 6 | 10 | 8 | 18 | 8 | 9 | 10 | 3 | 8 | 5 | 2 |
| % R | 3.3 | 30 | 16. 7 | 13.3 | 16. 7 | 30 | 13.3 | 16.7 | 3.3 | 20 | 43.3 | – | – | 3.3 | 33.3 | 20 | 33.3 | 26.7 | 60 | 26.7 | 30 | 33.3 | 10 | 26.7 | 16.7 | 6.7 | |
| % (I + R) | 33.3 | 30 | 46.7 | 30 | 23.3 | 43.3 | 3.3 | 53.3 | 60 | 86.7 | 63.3 | 36.7 | 23.3 | ||||||||||||||
Since all isolates were susceptible to Amikacin, Chloramphenicol, Cefoxitin, Ceftriaxone and Sulfamethoxazole + Trimethoprim, they were not included in the table
Amp Ampicillin, Amc Amoxicillin and clavulanic acid, Cf Cephalothin, Cip Ciprofloxacin, Gm Gentamicin, K Kanamycin, Tmp Trimethoprim, Te Tetracycline, Su Sulfisoxazole, S Streptomycin, Nitro Nitrofurantoin, Na Nalidixic acid, N Neomycin, I Intermediate, R Resistant